Cargando…
Revisiting the Tenascins: Exploitable as Cancer Targets?
For their full manifestation, tumors require support from the surrounding tumor microenvironment (TME), which includes a specific extracellular matrix (ECM), vasculature, and a variety of non-malignant host cells. Together, these components form a tumor-permissive niche that significantly differs fr...
Autores principales: | Tucker, Richard P., Degen, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248440/ https://www.ncbi.nlm.nih.gov/pubmed/35785162 http://dx.doi.org/10.3389/fonc.2022.908247 |
Ejemplares similares
-
Tenascin-W: Discovery, Evolution, and Future Prospects
por: Degen, Martin, et al.
Publicado: (2021) -
The Expression and Possible Functions of Tenascin-W During Development and Disease
por: Tucker, Richard P., et al.
Publicado: (2019) -
Tenascin-C: Exploitation and collateral damage in cancer management
por: Spenlé, Caroline, et al.
Publicado: (2015) -
The evolution of tenascins and fibronectin
por: Adams, Josephine C, et al.
Publicado: (2015) -
Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
por: Brellier, Florence, et al.
Publicado: (2012)